Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: Trend watching in biotherapeutics

The field of biotherapeutics – treatments produced by, or involving, living cells – is quickly evolving with the popularity and pursuit of new cell therapies. If you’re a student or young professional working in this space, you know this already. But how familiar are...

Right Turn: Recharging

Hi Signals readers, We hope you’ve had a great summer and enjoyed all of our posts so far in 2019. There is still lots to come, but we’re on vacation this week so we can recharge and come back in September full of energy and brimming with fresh ideas. May...

Bringing innovative cell and gene therapy products to Canadians

Siofradh McMahon is Senior Manager, Clinical Translation and Regulatory Affairs at CCRM. Síofradh works with academic and industry partners to advance promising products and technologies to commercialization. Having worked worldwide, Síofradh brings more than a decade...

Science matters. Stand up for science!

Canadian science groups and a non-partisan organization that promotes the “transparent use of evidence in government decision-making in Canada” have come together to launch a national campaign before Canadians go to the polls this fall to elect their federal...

Business of Regenerative Medicine Conference 2019: The rundown

Matthew Mistry is a Market and Equity Analyst at CCRM, where he conducts investment diligence, market analyses, participates in company creation activities and supports strategic business development. He joined CCRM from the Ontario Bioscience Innovation Organization...

Subscribe to Signals

Subscribe to our blog list to receive the latest news and updates.

You have Successfully Subscribed!